Stock Research: Boston Scientific

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Boston Scientific

NYSE:BSX US1011371077
71
  • Value
    50
  • Growth
    83
  • Safety
    Safety
    6
  • Combined
    43
  • Sentiment
    100
  • 360° View
    360° View
    71
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Boston Scientific Corporation is a global medical device developer, manufacturer, and marketer. It operates in the medical device industry, with segments including MedSurg and Cardiovascular. It operates globally. In the last fiscal year, the company had a market cap of $153,093 million, profits of $11,509 million, and revenue of $16,747 million with 53,000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 71 (better than 71% compared with alternatives), overall professional sentiment and financial characteristics for the stock Boston Scientific are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Boston Scientific. The consolidated Growth Rank has a good rank of 83, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 83% of competitors in the same industry. The consolidated Safety Rank at 50 means that the company has a financing structure that is safer than 50% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 100, which means that professional investors are more optimistic about the stock than for 100% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 6, meaning that the share price of Boston Scientific is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 94% of alternative stocks in the same industry. ...read more

more
Index
Diversity USA
Renewables Users
Recycling
D.J. US Medical Equipment
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 7 19 53
Growth
83 57 67 83
Safety
Safety
50 62 16 18
Sentiment
100 100 96 45
360° View
360° View
71 74 51 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
93 82 84 66
Opinions Change
99 95 52 52
Pro Holdings
n/a 80 98 20
Market Pulse
83 83 74 64
Sentiment
100 100 96 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 7 19 53
Growth
83 57 67 83
Safety Safety
50 62 16 18
Combined
43 29 12 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
23 19 42 67
Price vs. Earnings (P/E)
11 9 26 52
Price vs. Book (P/B)
20 24 36 64
Dividend Yield
1 1 1 1
Value
6 7 19 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
63 66 48 39
Profit Growth
73 56 66 75
Capital Growth
40 1 51 74
Stock Returns
89 91 77 85
Growth
83 57 67 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
50 49 34 31
Refinancing
5 4 1 9
Liquidity
82 94 83 67
Safety Safety
50 62 16 18

Similar Stocks

Discover high‑ranked alternatives to Boston Scientific and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.